262 related articles for article (PubMed ID: 33993608)
1. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608
[TBL] [Abstract][Full Text] [Related]
2. A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO).
Barrea L; Muscogiuri G; Annunziata G; Laudisio D; de Alteriis G; Tenore GC; Colao A; Savastano S
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31185686
[No Abstract] [Full Text] [Related]
3. Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome.
Barrea L; Annunziata G; Muscogiuri G; Di Somma C; Laudisio D; Maisto M; de Alteriis G; Tenore GC; Colao A; Savastano S
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30551613
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort.
Post A; Garcia E; van den Berg EH; Flores-Guerrero JL; Gruppen EG; Groothof D; Westenbrink BD; Connelly MA; Bakker SJL; Dullaart RPF
Eur J Clin Invest; 2021 Dec; 51(12):e13627. PubMed ID: 34120339
[TBL] [Abstract][Full Text] [Related]
5. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
[TBL] [Abstract][Full Text] [Related]
6. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.
Chen YM; Liu Y; Zhou RF; Chen XL; Wang C; Tan XY; Wang LJ; Zheng RD; Zhang HW; Ling WH; Zhu HL
Sci Rep; 2016 Jan; 6():19076. PubMed ID: 26743949
[TBL] [Abstract][Full Text] [Related]
7. Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease.
Ma R; Shi G; Li Y; Shi H
Br J Nutr; 2024 Jun; 131(11):1915-1923. PubMed ID: 38443197
[TBL] [Abstract][Full Text] [Related]
8. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
Gruppen EG; Garcia E; Connelly MA; Jeyarajah EJ; Otvos JD; Bakker SJL; Dullaart RPF
Sci Rep; 2017 Oct; 7(1):13781. PubMed ID: 29061990
[TBL] [Abstract][Full Text] [Related]
9. Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
Shi C; Pei M; Wang Y; Chen Q; Cao P; Zhang L; Guo J; Deng W; Wang L; Li X; Gong Z
Biochem Biophys Res Commun; 2022 Feb; 594():1-7. PubMed ID: 35065293
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
[TBL] [Abstract][Full Text] [Related]
11. Association of trimethylamine
Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
León-Mimila P; Villamil-Ramírez H; Li XS; Shih DM; Hui ST; Ocampo-Medina E; López-Contreras B; Morán-Ramos S; Olivares-Arevalo M; Grandini-Rosales P; Macías-Kauffer L; González-González I; Hernández-Pando R; Gómez-Pérez F; Campos-Pérez F; Aguilar-Salinas C; Larrieta-Carrasco E; Villarreal-Molina T; Wang Z; Lusis AJ; Hazen SL; Huertas-Vazquez A; Canizales-Quinteros S
Diabetes Metab; 2021 Mar; 47(2):101183. PubMed ID: 32791310
[TBL] [Abstract][Full Text] [Related]
13. Circulating Trimethylamine-N-Oxide Is Elevated in Liver Transplant Recipients.
Trillos-Almanza MC; Chvatal-Medina M; Connelly MA; Moshage H; TransplantLines Investigators ; Bakker SJL; de Meijer VE; Blokzijl H; Dullaart RPF
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892218
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress is associated with suspected non-alcoholic fatty liver disease and all-cause mortality in the general population.
Damba T; Bourgonje AR; Abdulle AE; Pasch A; Sydor S; van den Berg EH; Gansevoort RT; Bakker SJL; Blokzijl H; Dullaart RPF; van Goor H; Moshage H
Liver Int; 2020 Sep; 40(9):2148-2159. PubMed ID: 32558346
[TBL] [Abstract][Full Text] [Related]
15. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
16. Association of Circulating Trimethylamine
Flores-Guerrero JL; Osté MCJ; Baraldi PB; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477634
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
18. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis.
Farhangi MA
Nutrition; 2020 Oct; 78():110856. PubMed ID: 32592979
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
